Technical Analysis for PYPD - PolyPid Ltd.

Grade Last Price % Change Price Change
D 5.00 4.78% 0.23
PYPD closed up 4.78 percent on Wednesday, May 1, 2024, on 3.4 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 8
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Up

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Stochastic Reached Overbought Strength 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
NR7 Range Contraction 4.78%
Narrow Range Bar Range Contraction 4.78%

   Recent Intraday Alerts

Alert Time
50 DMA Resistance about 3 hours ago
50 DMA Support about 4 hours ago
3x Volume Pace about 4 hours ago
Possible Pocket Pivot about 4 hours ago
Rose Above Previous Day's High about 5 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID–500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Infection Phosphates Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site

Is PYPD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.23
52 Week Low 3.601
Average Volume 2,568
200-Day Moving Average 6.14
50-Day Moving Average 4.98
20-Day Moving Average 4.57
10-Day Moving Average 4.63
Average True Range 0.21
RSI (14) 57.45
ADX 14.4
+DI 34.66
-DI 27.28
Chandelier Exit (Long, 3 ATRs) 4.45
Chandelier Exit (Short, 3 ATRs) 4.84
Upper Bollinger Bands 4.95
Lower Bollinger Band 4.20
Percent B (%b) 1.07
BandWidth 16.48
MACD Line -0.05
MACD Signal Line -0.14
MACD Histogram 0.0902
Fundamentals Value
Market Cap 23.99 Million
Num Shares 4.8 Million
EPS -23.64
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 0.00
Price-to-Book 9.38
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.43
Resistance 3 (R3) 5.42 5.25 5.36
Resistance 2 (R2) 5.25 5.14 5.26 5.34
Resistance 1 (R1) 5.13 5.07 5.04 5.14 5.31
Pivot Point 4.96 4.96 4.92 4.97 4.96
Support 1 (S1) 4.84 4.85 4.76 4.86 4.69
Support 2 (S2) 4.67 4.78 4.68 4.66
Support 3 (S3) 4.55 4.67 4.64
Support 4 (S4) 4.57